Emergent BioSolutions Q3 EPS $(1.27) Misses $(0.06) Estimate, Sales $240.00M Miss $268.30M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(1.27) per share which missed the analyst consensus estimate of $(0.06) by 2016.67 percent. This is a 252.78 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $240.00 million which missed the analyst consensus estimate of $268.30 million by 10.55 percent. This is a 27.05 percent decrease over sales of $329.00 million the same period last year.